Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Schoch, Sarah; Sen, Vasily; Brenner, Walburgis et al.
In Vitro Nephrotoxicity Studies of Established and Experimental Platinum-Based CompoundsBIOMEDICINES. Bd. 9. H. 8. 2021
Wachholz, Vanessa; Mustafa, Al-Hassan M.; Zeyn, Yanira et al.
Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3ARCHIVES OF TOXICOLOGY. Bd. 96. H. 1. 2021 S. 177-193
Almstedt, Katrin; Sehouli, Jalid; Hasenburg, Annette
Innovations in follow-up care and therapy monitoring in ovarian cancer Changes in oncological therapy concepts have an impact on the follow-up care phaseONKOLOGE. Bd. 27. H. 12. 2021 S. 1245-1254
Anic, K.; Battista, M. J.; Hasenburg, A. et al.
Lee Schonberg prognostic index collected preoperatively as an independent Prognostic Factor for elderly Female Patients with Endometrial Cancer - Results of a retrospective Cohort StudyZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 54. H. SUPPL 1. 2021 S. S57-S57
Linz, Valerie C.; Battista, Marco J.; Jakel, Joerg et al.
Management of gestational trophoblastic diseaseONKOLOGE. Bd. 27. H. 9. 2021 S. 941-952
Krajnak, Slavomir; Battista, Marco J.; Hasenburg, Annette et al.
Metronomic Chemotherapy for Metastatic Breast CancerONCOLOGY RESEARCH AND TREATMENT. 2021
Schmidt, Marcus; Kuemmel, Sherko; Ruf-Doerdelmann, Antonia et al.
Neo-adjuvant and/or Adjuvant Subcutaneous Trastuzumab (Herceptin (R)) in Patients With Early HER2-positive Breast Cancer: Real World Data from a German Observational Study - (NIS HerSCin)ANTICANCER RESEARCH. Bd. 41. H. 1. 2021 S. 485-496
Lueftner, Diana; Tesch, Hans; Schmidt, Marcus et al.
Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET studyEUROPEAN JOURNAL OF CANCER. Bd. 150. 2021 S. 268-277
Luftner, Diana; Tesch, Hans; Schmidt, Marcus et al.
Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: HTA-driven analyses from the ExteNET studyCANCER RESEARCH. Bd. 81. H. 4. 2021
Droste, A; Hönig, A; Hasenburg, A et al.
Neue Erkenntnisse vom San Antonio Breast Cancer Symposium 2020.Frauenarzt. Bd. 62. H. 3. 2021 S. 172-176